Logo image of CHRD

CHORD ENERGY CORP (CHRD) Stock Fundamental Analysis

NASDAQ:CHRD - Nasdaq - US6742152076 - Common Stock - Currency: USD

109.19  +1.08 (+1%)

After market: 109.19 0 (0%)

Fundamental Rating

5

Taking everything into account, CHRD scores 5 out of 10 in our fundamental rating. CHRD was compared to 211 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and the financial health of CHRD get a neutral evaluation. Nothing too spectacular is happening here. CHRD is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CHRD was profitable.
In the past year CHRD had a positive cash flow from operations.
Of the past 5 years CHRD 4 years were profitable.
Each year in the past 5 years CHRD had a positive operating cash flow.
CHRD Yearly Net Income VS EBIT VS OCF VS FCFCHRD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B -3B

1.2 Ratios

With a decent Return On Assets value of 6.63%, CHRD is doing good in the industry, outperforming 70.14% of the companies in the same industry.
CHRD has a Return On Equity (10.04%) which is in line with its industry peers.
The Return On Invested Capital of CHRD (7.76%) is better than 65.40% of its industry peers.
CHRD had an Average Return On Invested Capital over the past 3 years of 15.70%. This is significantly below the industry average of 23.79%.
The last Return On Invested Capital (7.76%) for CHRD is well below the 3 year average (15.70%), which needs to be investigated, but indicates that CHRD had better years and this may not be a problem.
Industry RankSector Rank
ROA 6.63%
ROE 10.04%
ROIC 7.76%
ROA(3y)16.4%
ROA(5y)-22.23%
ROE(3y)23.16%
ROE(5y)-60.5%
ROIC(3y)15.7%
ROIC(5y)15.04%
CHRD Yearly ROA, ROE, ROICCHRD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

With a decent Profit Margin value of 16.08%, CHRD is doing good in the industry, outperforming 65.40% of the companies in the same industry.
In the last couple of years the Profit Margin of CHRD has declined.
With a Operating Margin value of 21.26%, CHRD perfoms like the industry average, outperforming 53.55% of the companies in the same industry.
CHRD's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 54.83%, CHRD is doing good in the industry, outperforming 63.03% of the companies in the same industry.
CHRD's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 21.26%
PM (TTM) 16.08%
GM 54.83%
OM growth 3Y-17.8%
OM growth 5Y20.31%
PM growth 3Y-7.34%
PM growth 5YN/A
GM growth 3Y-4.26%
GM growth 5Y-3.06%
CHRD Yearly Profit, Operating, Gross MarginsCHRD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

4

2. Health

2.1 Basic Checks

CHRD has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CHRD has more shares outstanding
The number of shares outstanding for CHRD has been reduced compared to 5 years ago.
CHRD has a worse debt/assets ratio than last year.
CHRD Yearly Shares OutstandingCHRD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CHRD Yearly Total Debt VS Total AssetsCHRD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

CHRD has an Altman-Z score of 1.80. This is a bad value and indicates that CHRD is not financially healthy and even has some risk of bankruptcy.
CHRD has a better Altman-Z score (1.80) than 61.61% of its industry peers.
The Debt to FCF ratio of CHRD is 1.95, which is an excellent value as it means it would take CHRD, only 1.95 years of fcf income to pay off all of its debts.
CHRD has a Debt to FCF ratio of 1.95. This is amongst the best in the industry. CHRD outperforms 83.89% of its industry peers.
A Debt/Equity ratio of 0.09 indicates that CHRD is not too dependend on debt financing.
The Debt to Equity ratio of CHRD (0.09) is better than 76.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.95
Altman-Z 1.8
ROIC/WACC0.83
WACC9.38%
CHRD Yearly LT Debt VS Equity VS FCFCHRD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

CHRD has a Current Ratio of 0.89. This is a bad value and indicates that CHRD is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.89, CHRD is not doing good in the industry: 63.03% of the companies in the same industry are doing better.
A Quick Ratio of 0.83 indicates that CHRD may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.83, CHRD is doing worse than 60.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.89
Quick Ratio 0.83
CHRD Yearly Current Assets VS Current LiabilitesCHRD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

The earnings per share for CHRD have decreased strongly by -17.96% in the last year.
CHRD shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.52% yearly.
CHRD shows a strong growth in Revenue. In the last year, the Revenue has grown by 31.71%.
CHRD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.44% yearly.
EPS 1Y (TTM)-17.96%
EPS 3Y1.52%
EPS 5YN/A
EPS Q2Q%-20.78%
Revenue 1Y (TTM)31.71%
Revenue growth 3Y49.24%
Revenue growth 5Y20.44%
Sales Q2Q%11.96%

3.2 Future

Based on estimates for the next years, CHRD will show a decrease in Earnings Per Share. The EPS will decrease by -3.28% on average per year.
CHRD is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.21% yearly.
EPS Next Y-39.84%
EPS Next 2Y-26.83%
EPS Next 3Y-10.28%
EPS Next 5Y-3.28%
Revenue Next Year-12.78%
Revenue Next 2Y-7.62%
Revenue Next 3Y-4.21%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CHRD Yearly Revenue VS EstimatesCHRD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
CHRD Yearly EPS VS EstimatesCHRD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 10 20 30

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 6.99, which indicates a rather cheap valuation of CHRD.
CHRD's Price/Earnings ratio is rather cheap when compared to the industry. CHRD is cheaper than 84.83% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.30. CHRD is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 12.23, the valuation of CHRD can be described as correct.
CHRD's Price/Forward Earnings ratio is in line with the industry average.
CHRD is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.99
Fwd PE 12.23
CHRD Price Earnings VS Forward Price EarningsCHRD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHRD indicates a rather cheap valuation: CHRD is cheaper than 90.05% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CHRD is valued a bit cheaper than 63.51% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.42
EV/EBITDA 2.91
CHRD Per share dataCHRD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100

4.3 Compensation for Growth

CHRD has a very decent profitability rating, which may justify a higher PE ratio.
CHRD's earnings are expected to decrease with -10.28% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-26.83%
EPS Next 3Y-10.28%

5

5. Dividend

5.1 Amount

CHRD has a Yearly Dividend Yield of 4.72%, which is a nice return.
Compared to an average industry Dividend Yield of 6.48, CHRD pays a bit more dividend than its industry peers.
CHRD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 4.72%

5.2 History

CHRD has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CHRD Yearly Dividends per shareCHRD Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 5 10 15 20 25

5.3 Sustainability

CHRD pays out 53.63% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP53.63%
EPS Next 2Y-26.83%
EPS Next 3Y-10.28%
CHRD Yearly Income VS Free CF VS DividendCHRD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B
CHRD Dividend Payout.CHRD Dividend Payout, showing the Payout Ratio.CHRD Dividend Payout.PayoutRetained Earnings

CHORD ENERGY CORP

NASDAQ:CHRD (7/11/2025, 8:00:00 PM)

After market: 109.19 0 (0%)

109.19

+1.08 (+1%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners93.48%
Inst Owner ChangeN/A
Ins Owners0.89%
Ins Owner Change-5.93%
Market Cap6.31B
Analysts82.73
Price Target137.25 (25.7%)
Short Float %3.75%
Short Ratio2.74
Dividend
Industry RankSector Rank
Dividend Yield 4.72%
Yearly Dividend10.46
Dividend Growth(5Y)N/A
DP53.63%
Div Incr Years0
Div Non Decr Years0
Ex-Date05-21 2025-05-21 (1.3)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.29%
Min EPS beat(2)12.65%
Max EPS beat(2)21.92%
EPS beat(4)2
Avg EPS beat(4)3.86%
Min EPS beat(4)-11.89%
Max EPS beat(4)21.92%
EPS beat(8)4
Avg EPS beat(8)1.85%
EPS beat(12)5
Avg EPS beat(12)0.9%
EPS beat(16)9
Avg EPS beat(16)7.34%
Revenue beat(2)1
Avg Revenue beat(2)7.48%
Min Revenue beat(2)-2.64%
Max Revenue beat(2)17.6%
Revenue beat(4)3
Avg Revenue beat(4)11.94%
Min Revenue beat(4)-2.64%
Max Revenue beat(4)23.6%
Revenue beat(8)7
Avg Revenue beat(8)19.43%
Revenue beat(12)11
Avg Revenue beat(12)27.85%
Revenue beat(16)15
Avg Revenue beat(16)34.39%
PT rev (1m)0.05%
PT rev (3m)-13.74%
EPS NQ rev (1m)-1.66%
EPS NQ rev (3m)-26.41%
EPS NY rev (1m)-6.42%
EPS NY rev (3m)-20.56%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)-6.57%
Revenue NY rev (1m)-2.41%
Revenue NY rev (3m)-6.43%
Valuation
Industry RankSector Rank
PE 6.99
Fwd PE 12.23
P/S 1.17
P/FCF 15.42
P/OCF 2.69
P/B 0.73
P/tB 0.78
EV/EBITDA 2.91
EPS(TTM)15.62
EY14.31%
EPS(NY)8.93
Fwd EY8.18%
FCF(TTM)7.08
FCFY6.49%
OCF(TTM)40.65
OCFY37.23%
SpS93.18
BVpS149.24
TBVpS140.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.63%
ROE 10.04%
ROCE 10.16%
ROIC 7.76%
ROICexc 7.79%
ROICexgc 8.17%
OM 21.26%
PM (TTM) 16.08%
GM 54.83%
FCFM 7.6%
ROA(3y)16.4%
ROA(5y)-22.23%
ROE(3y)23.16%
ROE(5y)-60.5%
ROIC(3y)15.7%
ROIC(5y)15.04%
ROICexc(3y)17%
ROICexc(5y)16.36%
ROICexgc(3y)17.12%
ROICexgc(5y)16.47%
ROCE(3y)20.55%
ROCE(5y)19.7%
ROICexcg growth 3Y-34.65%
ROICexcg growth 5Y32.44%
ROICexc growth 3Y-35.69%
ROICexc growth 5Y31.18%
OM growth 3Y-17.8%
OM growth 5Y20.31%
PM growth 3Y-7.34%
PM growth 5YN/A
GM growth 3Y-4.26%
GM growth 5Y-3.06%
F-Score5
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.95
Debt/EBITDA 0.33
Cap/Depr 150.42%
Cap/Sales 36.02%
Interest Coverage 250
Cash Conversion 96.5%
Profit Quality 47.27%
Current Ratio 0.89
Quick Ratio 0.83
Altman-Z 1.8
F-Score5
WACC9.38%
ROIC/WACC0.83
Cap/Depr(3y)173.67%
Cap/Depr(5y)227.89%
Cap/Sales(3y)27.34%
Cap/Sales(5y)32.88%
Profit Quality(3y)53.44%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.96%
EPS 3Y1.52%
EPS 5YN/A
EPS Q2Q%-20.78%
EPS Next Y-39.84%
EPS Next 2Y-26.83%
EPS Next 3Y-10.28%
EPS Next 5Y-3.28%
Revenue 1Y (TTM)31.71%
Revenue growth 3Y49.24%
Revenue growth 5Y20.44%
Sales Q2Q%11.96%
Revenue Next Year-12.78%
Revenue Next 2Y-7.62%
Revenue Next 3Y-4.21%
Revenue Next 5YN/A
EBIT growth 1Y-6.45%
EBIT growth 3Y22.68%
EBIT growth 5Y44.91%
EBIT Next Year102.48%
EBIT Next 3Y30.34%
EBIT Next 5Y22.79%
FCF growth 1Y-72.22%
FCF growth 3Y33.26%
FCF growth 5Y149.9%
OCF growth 1Y10.35%
OCF growth 3Y31.89%
OCF growth 5Y18.62%